Roles of microRNAs in atherosclerosis and restenosis

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Chen, Li Jing ^a,b   Lim, Seh Hong ^a   Yeh, Yi Ting ^a,b   Lien, Sheng Chieh ^a,b   Chiu, Jeng Jiann ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 10A; MICRORNA 125A; MICRORNA 125B; MICRORNA 126; MICRORNA 130A; MICRORNA 132; MICRORNA 133; MICRORNA 143; MICRORNA 145; MICRORNA 146A; MICRORNA 150; MICRORNA 155; MICRORNA 17; MICRORNA 200A; MICRORNA 21; MICRORNA 210; MICRORNA 218; MICRORNA 221; MICRORNA 222; MICRORNA 26; MICRORNA 320; MICRORNA 424; MICRORNA 503; RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ATHEROSCLEROSIS; BIOGENESIS; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; MACROPHAGE; MONOCYTE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ATHEROSCLEROSIS; CELL DIFFERENTIATION; CORONARY RESTENOSIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84865418703     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-79     Document Type: Review

References (102)

1. Inflammation in atherosclerosis. Libby P, Nature 2002 420 6917 868 874
2. Shear stress inhibits adhesion molecule expression in vascular endothelial cells induced by coculture with smooth muscle cells. Chiu JJ, Chen LJ, Lee PL, Lee CI, Lo LW, Usami S, Chien S, Blood 2003 101 7 2667 2674
3. Atherosclerosis and restenosis: an inflammatory issue. Smith TP, Radiology 2002 225 1 10 12
4. Restenosis after PCI. Part 1: pathophysiology and risk factors. Jukema JW, Verschuren JJ, Ahmed TA, Quax PH, Nat Rev Cardiol 2012 9 1 53 62
5. Restenosis after coronary balloon angioplasty. Lange RA, Flores ED, Hillis LD, Annu Rev Med 1991 42 127 132
6. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Lee RC, Feinbaum RL, Ambros V, Cell 1993 75 5 843 854
7. Identification of hundreds of conserved and nonconserved human microRNAs. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z, Nat Genet 2005 37 7 766 770
8. miRBase: integrating microRNA annotation and deep-sequencing data. Kozomara A, Griffiths-Jones S, Nucleic Acids Res 2011 39 152 D157 Database issue
9. MicroRNomics: a newly emerging approach for disease biology. Zhang C, Physiol Genomics 2008 33 2 139 147
10. MicroRNAs in arterial remodelling, inflammation and atherosclerosis. Weber C, Schober A, Zernecke A, Curr Drug Targets 2010 11 8 950 956
11. The role of microRNAs in arterial remodelling. Nazari-Jahantigh M, Wei Y, Schober A, Thromb Haemost 2012 107 4 611 618
12. MicroRNAs in vascular disease. Qin S, Zhang C, J Cardiovasc Pharmacol 2011 57 1 8 12
13. MicroRNA genes are transcribed by RNA polymerase II. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN, EMBO J 2004 23 20 4051 4060
14. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. Cai X, Hagedorn CH, Cullen BR, RNA 2004 10 12 1957 1966
15. RNA polymerase III transcribes human microRNAs. Borchert GM, Lanier W, Davidson BL, Nat Struct Mol Biol 2006 13 12 1097 1101
16. The nuclear RNase III Drosha initiates microRNA processing. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN, Nature 2003 425 6956 415 419
17. The Microprocessor complex mediates the genesis of microRNAs. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R, Nature 2004 432 7014 235 240
18. The Drosha-DGCR8 complex in primary microRNA processing. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN, Genes Dev 2004 18 24 3016 3027
19. Posttranscriptional regulation of microRNA biogenesis in animals. Siomi H, Siomi MC, Mol Cell 2010 38 3 323 332
20. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A, Mol Cell 2010 39 3 373 384
21. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Yi R, Qin Y, Macara IG, Cullen BR, Genes Dev 2003 17 24 3011 3016
22. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Knight SW, Bass BL, Science 2001 293 5538 2269 2271
23. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD, Science 2001 293 5531 834 838
24. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R, Cell 2005 123 4 631 640
25. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Diederichs S, Haber DA, Cell 2007 131 6 1097 1108
26. Sorting of Drosophila small silencing RNAs partitions microRNA* strands into the RNA interference pathway. Ghildiyal M, Xu J, Seitz H, Weng Z, Zamore PD, RNA 2010 16 1 43 56
27. Distinct mechanisms for microRNA strand selection by Drosophila Argonautes. Okamura K, Liu N, Lai EC, Mol Cell 2009 36 3 431 444
28. Atherosclerosis. Lusis AJ, Nature 2000 407 6801 233 241
29. Inflammation, atherosclerosis, and coronary artery disease. Hansson GK, N Engl J Med 2005 352 16 1685 1695
30. Regulation of chemokine expression in atherosclerosis. Burke-Gaffney A, Brooks AV, Bogle RG, Vascul Pharmacol 2002 38 5 283 292
31. Role of oxidized LDL and antioxidants in atherosclerosis. Steinberg D, Adv Exp Med Biol 1995 369 39 48
32. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Owens GK, Kumar MS, Wamhoff BR, Physiol Rev 2004 84 3 767 801
33. Collagens in the progression and complications of atherosclerosis. Adiguzel E, Ahmad PJ, Franco C, Bendeck MP, Vasc Med 2009 14 1 73 89
34. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB, Circulation 1996 94 1 35 43
35. Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy. Bennett MR, O'Sullivan M, Pharmacol Ther 2001 91 2 149 166
36. Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials? Lafont A, Faxon D, Cardiovasc Res 1998 39 1 50 59
37. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF, Proc Natl Acad Sci USA 2010 107 30 13450 13455
38. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ, Proc Natl Acad Sci USA 2008 105 5 1516 1521
39. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN, Dev Cell 2008 15 2 261 271
40. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X, Guo Z, Liu J, Wang Y, Yuan W, Qin Y, Atherosclerosis 2011 215 2 286 293
41. MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells. Li D, Yang P, Xiong Q, Song X, Yang X, Liu L, Yuan W, Rui YC, J Hypertens 2010 28 8 1646 1654
42. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A, Soreq H, Immunity 2009 31 6 965 973
43. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S, Science 2009 324 5935 1710 1713
44. MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Grundmann S, Hans FP, Kinniry S, Heinke J, Helbing T, Bluhm F, Sluijter JP, Hoefer I, Pasterkamp G, Bode C, Moser M, Circulation 2011 123 9 999 1009
45. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Kuhnert F, Mancuso MR, Hampton J, Stankunas K, Asano T, Chen CZ, Kuo CJ, Development 2008 135 24 3989 3993
46. miR-126 regulates angiogenic signaling and vascular integrity. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D, Dev Cell 2008 15 2 272 284
47. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND, Nature 2010 464 7292 1196 1200
48. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM, Cheresh DA, Nat Med 2010 16 8 909 914
49. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, Robbins RC, Wu JC, Circulation 2010 122 11 Suppl 124 S131
50. miR-221 Is Required for Endothelial Tip Cell Behaviors during Vascular Development. Nicoli S, Knyphausen CP, Zhu LJ, Lakshmanan A, Lawson ND, Dev Cell 2012 22 2 418 429
51. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, Brizzi MF, Arterioscler Thromb Vasc Biol 2010 30 8 1562 1568
52. Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. Nakashima T, Jinnin M, Etoh T, Fukushima S, Masuguchi S, Maruo K, Inoue Y, Ishihara T, Ihn H, PLoS One 2010 5 12 14334
53. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Caporali A, Meloni M, Vollenkle C, Bonci D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH, Agami R, le Sage C, Condorelli G, Madeddu P, Martelli F, Emanueli C, Circulation 2011 123 3 282 291
54. MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. Sabatel C, Malvaux L, Bovy N, Deroanne C, Lambert V, Gonzalez ML, Colige A, Rakic JM, Noel A, Martial JA, Struman I, PLoS One 2011 6 2 16979
55. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X, Sun Q, Wang K, Ba Y, Wang Q, Wang D, Yang J, Liu P, Xu T, Yan Q, Zhang J, Zen K, Zhang CY, Mol Cell 2010 39 1 133 144
56. miR-200a modulate HUVECs viability and migration. Li YX, Liu DQ, Zheng C, Zheng SQ, Liu M, Li X, Tang H, IUBMB Life 2011 63 7 553 559
57. MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Small EM, Sutherland LB, Rajagopalan KN, Wang S, Olson EN, Circ Res 2010 107 11 1336 1344
58. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM, Clin Exp Pharmacol Physiol 2009 36 2 181 188
59. Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. Slevin M, Krupinski J, Badimon L, J Angiogenes Res 2009 1 4
60. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC, Circ Res 2007 100 8 1164 1173
61. Microarray profiling of monocytic differentiation reveals miRNA-mRNA intrinsic correlation. Wang J, Xiang G, Mitchelson K, Zhou Y, J Cell Biochem 2011 112 9 2443 2453
62. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F, Croce CM, Brunetti E, Grignani F, Peschle C, Nat Cell Biol 2007 9 7 775 787
63. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Rosa A, Ballarino M, Sorrentino A, Sthandier O, De Angelis FG, Marchioni M, Masella B, Guarini A, Fatica A, Peschle C, Bozzoni I, Proc Natl Acad Sci USA 2007 104 50 19849 19854
64. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y, de Hoon MJ, Kubosaki A, Kaiho A, Suzuki M, Yasuda J, Kawai J, Hayashizaki Y, Hume DA, Suzuki H, Leukemia 2010 24 2 460 466
65. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P, Proc Natl Acad Sci USA 2009 106 8 2735 2740
66. MicroRNA-155 is induced during the macrophage inflammatory response. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D, Proc Natl Acad Sci USA 2007 104 5 1604 1609
67. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. Huang RS, Hu GQ, Lin B, Lin ZY, Sun CC, J Investig Med 2010 58 8 961 967
68. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S, Wang C, Cardiovasc Res 2009 83 1 131 139
69. miR-33 links SREBP-2 induction to repression of sterol transporters. Marquart TJ, Allen RM, Ory DS, Baldan A, Proc Natl Acad Sci USA 2010 107 27 12228 12232
70. MiR-33 contributes to the regulation of cholesterol homeostasis. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernandez-Hernando C, Science 2010 328 5985 1570 1573
71. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C, Circ Res 2007 100 11 1579 1588
72. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C, Circ Res 2009 104 4 476 487
73. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Dzau VJ, Braun-Dullaeus RC, Sedding DG, Nat Med 2002 8 11 1249 1256
74. miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB, Su M, Han Y, Shi HJ, Wen JK, EMBO Rep 2011 12 1 56 62
75. MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Wu WH, Hu CP, Chen XP, Zhang WF, Li XW, Xiong XM, Li YJ, Am J Hypertens 2011 24 10 1087 1093
76. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A, J Biol Chem 2009 284 6 3728 3738
77. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM, J Cell Physiol 2011 226 4 1035 1043
78. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD, Bochicchio A, Vicinanza C, Aquila I, Curcio A, Condorelli G, Indolfi C, Circ Res 2011 109 8 880 893
79. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D, Nature 2009 460 7256 705 710
80. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C, Circ Res 2009 105 2 158 166
81. MicroRNA signatures in human cancers. Calin GA, Croce CM, Nat Rev Cancer 2006 6 11 857 866
82. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Zhou J, Wang KC, Wu W, Subramaniam S, Shyy JY, Chiu JJ, Li JY, Chien S, Proc Natl Acad Sci USA 2011 108 25 10355 10360
83. Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a. Wu W, Xiao H, Laguna-Fernandez A, Villarreal G, Wang KC, Geary GG, Zhang Y, Wang WC, Huang HD, Zhou J, Li YS, Chien S, Garcia-Cardena G, Shyy JY, Circulation 2011 124 5 633 641
84. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Ni CW, Qiu H, Jo H, Am J Physiol Heart Circ Physiol 2011 300 5 1762 H1769
85. MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Qin X, Wang X, Wang Y, Tang Z, Cui Q, Xi J, Li YS, Chien S, Wang N, Proc Natl Acad Sci USA 2010 107 7 3240 3244
86. Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth. Wang KC, Garmire LX, Young A, Nguyen P, Trinh A, Subramaniam S, Wang N, Shyy JY, Li YS, Chien S, Proc Natl Acad Sci USA 2010 107 7 3234 3239
87. Circulating microRNAs in patients with coronary artery disease. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S, Circ Res 2010 107 5 677 684
88. miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Guo M, Mao X, Ji Q, Lang M, Li S, Peng Y, Zhou W, Xiong B, Zeng Q, Immunol Cell Biol 2010 88 5 555 564
89. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. Takahashi Y, Satoh M, Minami Y, Tabuchi T, Itoh T, Nakamura M, Clin Sci 2010 119 9 395 405
90. The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome. Yao R, Ma Y, Du Y, Liao M, Li H, Liang W, Yuan J, Ma Z, Yu X, Xiao H, Liao Y, Cell Mol Immuno 2011 8 6 486 495
91. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Li T, Cao H, Zhuang J, Wan J, Guan M, Yu B, Li X, Zhang W, Clin Chim Acta 2011 412 1-2 66 70
92. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Raitoharju E, Lyytikainen LP, Levula M, Oksala N, Mennander A, Tarkka M, Klopp N, Illig T, Kahonen M, Karhunen PJ, Laaksonen R, Lehtimaki T, Atherosclerosis 2011 219 1 211 217
93. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Taganov KD, Boldin MP, Chang KJ, Baltimore D, Proc Natl Acad Sci USA 2006 103 33 12481 12486
94. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Fichtlscherer S, Zeiher AM, Dimmeler S, Arterioscler Thromb Vasc Biol 2011 31 11 2383 2390
95. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO, Nat Cell Biol 2007 9 6 654 659
96. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Lim PK, Bliss SA, Patel SA, Taborga M, Dave MA, Gregory LA, Greco SJ, Bryan M, Patel PS, Rameshwar P, Cancer Res 2011 71 5 1550 1560
97. MicroRNA-21 as therapeutic target in cancer and cardiovascular disease. Bonci D, Recent Pat Cardiovasc Drug Discov 2010 5 3 156 161
98. Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. Lin Y, Liu X, Cheng Y, Yang J, Huo Y, Zhang C, J Biol Chem 2009 284 12 7903 7913
99. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L, Braun T, J Clin Invest 2009 119 9 2634 2647
100. The knockout of miR-143 and 145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli G, Cell Death Differ 2009 16 12 1590 1598
101. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, Olson EN, Genes Dev 2009 23 18 2166 2178
102. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC, Arterioscler Thromb Vasc Biol 2010 30 6 1118 1126